HAGOS score, baseline and 4-month assessment and SF-36 score, baseline assessment
| Mean | SD | Median | Range | Floor effects | Ceiling effects | |
|---|---|---|---|---|---|---|
| HAGOS – baseline (n = 101) | ||||||
| Pain | 64.0 | 19.7 | 68 | 10–95 | 0 | 0 |
| Symptoms | 56.9 | 18.5 | 61 | 11–89 | 0 | 0 |
| ADL | 68.1 | 23.2 | 70 | 0–100 | 1 (1) | 9 (8.9) |
| Sport/Rec | 45.5 | 25.9 | 44 | 0–100 | 1 (1.0) | 2 (2.0) |
| PA* | 25.8 | 29.0 | 13 | 0–100 | 39 (39) | 3 (3.0) |
| QOL | 33.5 | 16.1 | 35 | 5–75 | 0 | 0 |
| HAGOS – 4 months (n = 87) | ||||||
| Pain | 73.4 | 19.4 | 75 | 30–100 | 0 | 5 |
| Symptoms | 67.8 | 20.2 | 68 | 18–100 | 0 | 4 |
| ADL | 75.8 | 22.9 | 80 | 15–100 | 0 | 19 (18.8) |
| Sport/Rec† | 56.9 | 27.2 | 56 | 3–100 | 0 | 7 (7) |
| PA† | 36.1 | 34.2 | 25 | 0–100 | 28 (28) | 7 (6.9) |
| QOL | 45.6 | 23.4 | 45 | 5–95 | 0 | 0 |
| SF-36 – baseline (n = 101) | ||||||
| SF-36 PF | 70.5 | 19.7 | 75 | 20–100 | 0 | 3 (3.0) |
| SF-36 RP | 65.6 | 35.2 | 75 | 0–100 | 13 (12.9) | 40 (39.6) |
| SF-36 BP | 54.3 | 20.0 | 61 | 0–84 | 3 (3) | 0 |
| SF-36 GH | 74.5 | 18.3 | 77 | 20–100 | 0 | 7 (6.9) |
| SF-36 VT | 62.2 | 19.3 | 65 | 5–100 | 0 | 1 (1) |
| SF-36 SF | 90.1 | 18.2 | 100 | 12.5–100 | 0 | 67 (66.3) |
| SF-36 RE | 86.8 | 28.3 | 100 | 0–100 | 6 (5.9) | 79 (78.2) |
| SF-36 MH | 77.5 | 15.3 | 80 | 28–100 | 0 | 3 (3) |
↵* n = 100;
↵† n = 86.
ADL, Activities of Daily Living; BP, Bodily Pain; GH, General Health; HAGOS, Copenhagen Hip and Groin Outcome Score; MH, Mental Health; PA, Participation in Physical Activity; PF, Physical Functioning; QOL, Quality of Life; RE, Role-Emotional; RP, Role-Physical; SF, Social Functioning; SF-36, Short Form-36 items; Sport/Rec, Sport and Recreation function; VT, Vitality.